Attached files
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We have issued our report dated June 22, 2018, with respect to the financial statements of Arog Pharmaceuticals, Inc. contained in the Registration Statement and Prospectus. We consent to the use of the aforementioned report in the Registration Statement and Prospectus, and to the use of our name as it appears under the caption “Experts”.
/s/ GRANT THORNTON LLP
Dallas, Texas
September 28, 2018